Recent investigations have shown that special frequencies and intensities of electromagnetic waves could control the differentiations of some types of cells. Using this fact, tumor-treating fields (TTFields) therapy has been proposed as a technique which uses alternating electric fields of intermediate frequency (~100–500 kHz) and low intensity (1–3 V/cm) to disrupt the cell divisions of tumors. However, this technique may have harmful effects on ionic liquids around normal cells. For example, electrodes could induce an extra electrical current within blood vessels. To observe these effects, we connected electrodes to a slide that includes water and some extra ions and put them under a 1000× microscope. We found that some ions, microbes and cells move toward negative electrons and some go away. These attractions of cells by electrodes could cause the destruction of the brain. We also found some electrical currents within the liquid emerge which absorb or repel water molecules and induce some bubbles. If these types of bubbles arise within the blood vessels, they can exert a force on the membranes of normal cells and destroy them. To avoid these problems, we suggest that electrodes should be replaced by some electromagnetic sender/receiver which emits some special frequencies. These frequencies could be absorbed only by blood vessels around the tumors because these vessels may be created only to provide the needed food for tumor cells and thus have a different potential and electrical current as compared to vessels around normal cells. Thus, these tumor vessels could act as the antenna for TTFields.
Citation: Massimo Fioranelli, Alireza Sepehri. A comment to improve tumor-treating fields therapy[J]. AIMS Bioengineering, 2023, 10(1): 13-23. doi: 10.3934/bioeng.2023002
Recent investigations have shown that special frequencies and intensities of electromagnetic waves could control the differentiations of some types of cells. Using this fact, tumor-treating fields (TTFields) therapy has been proposed as a technique which uses alternating electric fields of intermediate frequency (~100–500 kHz) and low intensity (1–3 V/cm) to disrupt the cell divisions of tumors. However, this technique may have harmful effects on ionic liquids around normal cells. For example, electrodes could induce an extra electrical current within blood vessels. To observe these effects, we connected electrodes to a slide that includes water and some extra ions and put them under a 1000× microscope. We found that some ions, microbes and cells move toward negative electrons and some go away. These attractions of cells by electrodes could cause the destruction of the brain. We also found some electrical currents within the liquid emerge which absorb or repel water molecules and induce some bubbles. If these types of bubbles arise within the blood vessels, they can exert a force on the membranes of normal cells and destroy them. To avoid these problems, we suggest that electrodes should be replaced by some electromagnetic sender/receiver which emits some special frequencies. These frequencies could be absorbed only by blood vessels around the tumors because these vessels may be created only to provide the needed food for tumor cells and thus have a different potential and electrical current as compared to vessels around normal cells. Thus, these tumor vessels could act as the antenna for TTFields.
| [1] |
Kirson ED, Gurvich Z, Schneiderman R, et al. (2004) Disruption of cancer cell replication by alternating electric fields. Cancer Res 64: 3288-3295. https://doi.org/10.1158/0008-5472 
|
| [2] |
Davies AM, Weinberg U, Palti Y (2013) Tumor treating fields: a new frontier in cancer therapy. Ann NY Acad Sci 1291: 86-95. https://doi.org/10.1111/nyas.12112
|
| [3] |
Rominiyi O, Vanderlinden A, Clenton SJ, et al. (2020) Tumour treating fields therapy for glioblastoma: current advances and future directions. Br J Cancer 124: 697-709. https://doi:10.1038/s41416-020-01136-5
|
| [4] |
Wick W (2016) TTFields: where does all the skepticism come from?. Neuro-Oncology 18: 303-305. https://doi:10.1093/neuonc/now012
|
| [5] |
Stupp R, Wong E, Scott C, et al. (2014) Interim analysis of the EF-14 trial: A prospective, multi-center trial of novoTTF-100A together with temozolomide compared to temozolomide alone in Patients with newly diagnosed GBM. Neuro-Oncology 16: v167. https://doi:10.1093/neuonc/nou265.40
|
| [6] |
Vergote I, von Moos R, Manso L, et al. (2018) Tumor treating fields in combination with paclitaxel in recurrent ovarian carcinoma: results of the innovate pilot study. Gynecol Oncol 150: 471-477. https://doi:10.1016/j.ygyno.2018.07.018
|
| [7] |
Wenger C, Miranda PC, Salvador R, et al. (2018) A review on tumor-treating fields (TTFields): clinical implications inferred from computational modeling. IEEE Reviews in Biomedical Engineering 11: 195-207. https://doi:10.1109/RBME.2017.2765282
|
| [8] |
Voloshin T, Kaynan N, Davidi S, et al. (2020) Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. Cancer Immunol Immunother 69: 1191-1204. https://doi.org/10.1007/s00262-020-02534-7
|
| [9] |
Shteingauz A, Porat Y, Voloshin T, et al. (2018) AMPK-dependent autophagy upregulation serves as a survival mechanism in response to tumor treating fields (TTFields). Cell Death Dis 9: 1074. https://doi.org/10.1038/s41419-018-1085-9
|
| [10] |
Gentilal N, Salvador R, Miranda PC (2019) Temperature control in TTFields therapy of GBM: impact on the duty cycle and tissue temperature. Phys Med Biol 64: 225008. https://doi.org/10.1088/1361-6560/ab5323
|
| [11] |
Tuszynski JA, Wenger C, Friesen DE, et al. (2016) An overview of sub-cellular mechanisms involved in the action of TTFields. Int J Environ Res Public Health 13: 1128. https://doi.org/10.3390/ijerph13111128
|
Figures(10)
Massimo Fioranelli, Alireza Sepehri. A comment to improve tumor-treating fields therapy[J]. AIMS Bioengineering, 2023, 10(1): 13-23. doi: 10.3934/bioeng.2023002
DownLoad: